FDA NDC Directory · JSON-LD · Markdown

BORTEZOMIB

NDC 0409-1704 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerHospira, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA209191
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsBORTEZOMIB (1 mg/1)
Marketing started20220516
Package count1

External sources

Source: openFDA. Public-domain (CC0).